Most U.S. cannabis multistate operators reported modest to significant year-over-year revenue gains.
Among the companies with the highest revenue in the third quarter were Curaleaf Holdings CURLF with $339 million followed by Trulieve Cannabis TCNNF with $300 million.
In a similar range was Green Thumb Industries GTBIF with $261 million, Verano Holdings VRNOF ($228M), and Cresco Labs CRLBF ($210M), followed by Columbia Care CCHWF with $132M, Ayr Wellness AYRWF with $119.6M, Ascend Wellness Holdings AAWH ($111M), Jushi Holdings JUSHF ($72.8M), TerrAscend TSRRF ($67M) and Acreage Holdings ACRHF ($61.4).
Those with a presence in emerging markets, such as New Jersey, experienced significant year-over-year growth in revenues in the third quarter of 2022. According to MJBizDaily Curaleaf increased its revenues by 7%, Green Thumb Industries by 11.8%, Verano Holdings by 10%, Columbia Care by 0.3%, Ascend Wellness by 17.9%, TerrAscend 36.4% and Acreage Holdings by 28%.
The highest QoQ % change in revenue was that of Ascend Wellness, with a %14.1 increase.
Among those companies with the highest profit loss was Truelieve with -$114.55 million and TerrAscend with -$55.8 million, followed closely by Jushi Holdings with -$52.9 million and Curaleaf with -$51.4 million lost.
Only Chicago-based Green Thumb Industries reported a profit for that quarter, at $131 million. “That’s a 506% increase from a year ago when Green Thumb reported a $21.6 million profit for the same period,” reported journalist Kate Robertson for MJBizDaily.
Image By Tania Dimas On Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.